Hamid Khoja

Recent appearances

• 

  The Fibroblast Answer to $4T in Chronic Disease | CEO Pete O'Heeron on Fibrobiologics (Nasdaq: FBLG)

  September 23, 2026 · 📺 RedChip Companies

  CEO Pete O'Heeron and Chief Scientific Officer Dr. Hamid Khoja join RedChip to detail how FibroBiologics (Nasdaq: FBLG) is building a fibroblast-based cell therapy platform aimed at chronic diseases that remain uncured despite decades of pharmaceutical innovation. Fibroblasts are the most abundant cell type in the body, yet they have long been overlooked in favor of immune cells and stem cells. FibroBiologics' allogeneic approach allows one donor to treat many patients, with low rejection risk, low manufacturing costs, and a scalable spheroid delivery platform. Because fibroblasts are already…

  Watch on YouTube ↗

• 

  Unlocking The Therapeutic Power Of Fibroblasts With Pete O’Heeron And Hamid Khoja, Ph.D.

  February 24, 2026 · 📺 Life Science Connect

  In this episode of “Better Biopharma,” host Tyler Menichiello is joined by FibroBiologics’ CEO and Founder, Pete O’Heeron, and chief scientific officer, Hamid Khoja, Ph.D. They discuss the powerful but often overlooked fibroblast, a type of connective-tissue cell that has tremendous therapeutic potential, according to O’Heeron and Khoja. They explain the company’s mission to realize this therapeutic potential and make fibroblasts a mainstay in the cell therapy space, rivaling the prominence of stem cells. Follow Tyler Menichiello on LinkedIn:   / tmenichiello   Keep up with everything bioman…

  Watch on YouTube ↗

• 

  FibroBiologics

  January 05, 2026 · 📺 Alliance for Regenerative Medicine

  Hamid Khoja, Ph.D., Chief Scientific Officer FibroBiologics is a clinical-stage biotechnology company focused on developing and commercializing fibroblast cell-based therapies for patients suffering from chronic diseases. Our proprietary fibroblast platform serves as the foundation for developing biologic cures and treatments for chronic diseases, including wound healing multiple sclerosis, degenerative disc disease, psoriasis, cancer, and anti-aging extension of life applications such as thymic involution reversal. Currently, FibroBiologics holds 240+ U.S. and International issued/pending pa…

  Watch on YouTube ↗

• 

  #336 - Dr. Hamid Khoja, Chief Scientific Officer at FibroBiologics

  April 05, 2023 · 📺 Slice of Healthcare Network

  Our Guest: Dr. Hamid Khoja, Chief Scientific Officer at FibroBiologics What you'll get out of this episode: 🩺 Dr. Khoja's background 🧬 An overview of FibroBiologics ⚖️ Fibroblasts in comparison to stem cells 💊 What diseases they are currently focused on and why? 📝 Where the company is at regarding clinical studies 🔮 What's next? Our sponsors for this episode are Sage Growth Partners & FlipMD Sage Growth Partners accelerates commercial success for healthcare organizations through a singular focus on growth. The company helps its clients thrive amid the complexities of a rapidly changing mark…

  Watch on YouTube ↗

• 

  Exploring The Benefits Of Fibroblast Regenerative Therapeutics With Hamid Khoja

  July 14, 2022 · 📺 Finding Genius Podcast

  Please Support The Channel by clicking here: ▀▀▀▀▀▀▀▀▀▀▀▀▀▀ Buy Me A Coffee: https://bit.ly/3Lw7YvI Support us on Patreon: https://bit.ly/3BmEInH ▀▀▀▀▀▀▀▀▀▀▀▀▀▀ Episode also available on Apple Podcasts: apple.co/30PvU9C Checkout FGP Website: https://www.findinggeniuspodcast.com/ SUBSCRIBE & REVIEW our Podcast on iTunes: https://apple.co/2L6tN88 Follow us on: Facebook:   / futuretechpodcast   Twitter:   / finding_genius   Instagram:   / findinggeniuspodcast   LinkedIn:   / finding-genius-podcast   Timestamps: 0:00 Ad Introduction 0:50 FGP Introduction 2:57 Guest introduction 4:00 What i…

  Watch on YouTube ↗

• 

  Dr. Hamid Khoja: Using Fibroblasts to Treat Chronic Diseases

  July 12, 2022 · 📺 DocWire

  What are fibroblasts ...

  Watch on YouTube ↗

• 

  Fibroblasts In Regenerative Medicine With FibroBiologics' Pete O'Heeron & Dr. Hamid Khoja

  June 21, 2022 · 📺 Life Science Connect

  FibroBiologics Chairman, CEO, & Founder Pete O'Heeron shares the journey that led him from clinical care to biopharma entrepreneurship, and he's joined by Chief Scientific Officer Hamid Khoja, Ph.D., who explains the manufacturing technology that's driving the company's exploitation of fibroblasts to develop regenerative therapies for indications ranging from degenerative disk disease and multiple sclerosis to cancer immunotherapies and therapeutics. #businessofbiotech #biopharma #biotech #cytiva http://cytiva.com/emergingbiotech Audio version available here: https://www.bioprocessonline.c…

  Watch on YouTube ↗

• 

  FibroBiologics - Fibroblasts - The Regenerative Medicine That Will Replace Stem Cells

  February 19, 2022 · 📺 HPR

  Dr. Hamid Khoja, Chief Scientific Officer at FibroBiologics, a regenerative medicine company developing treatment for chronic diseases using fibroblasts, talks about what fibroblasts are and how it could replace stem cell technology. The company’s indication of focus is multiple sclerosis and their fibroblast technology has demonstrated the ability to remyelinate nerve cells in pre-clinical studies. Small human efficacy studies have thus far demonstrated that treatment with fibroblasts helps improve the cognition and finger dexterity of MS patients. #FibroBiologics Dr. Hamid Khoja, Chi…

  Watch on YouTube ↗